News & Media
Press Releases
ImmuneID Appoints Jessica Atkinson as Chief Business Officer
October 17, 2022
ImmuneID Announces Appointment of Pam Stetkiewicz, Ph.D., to Board of Directors
July 12, 2022
ImmuneID Appoints Jeremiah Degenhardt, Ph.D., as SVP Computational Biology
February 1, 2022
ImmuneID Appoints Veteran Biotech Executive James S. Scibetta as CEO
September 21, 2021
ImmuneID Announces Close of $50 Million Series A Financing to Develop Precision Immunology Therapeutics
June 23, 2021
ImmuneID Appoints Annalisa D’Andrea as President and Chief Scientific Officer
April 5, 2021
ImmuneID Launches with $17M Financing to Profile and Modulate Immune Response at Unprecedented Scale and Resolution
February 17, 2021
In The News
Publications
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
January 13, 2022
High-resolution epitope mapping reveals interplay between IgE and IgG repertoires during peanut oral immunotherapy
October 19, 2021
Profiling serum antibodies with a pan allergen phage library identifies key wheat allergy epitopes
2021
Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
October 23, 2020
A viral exposure signature defines early onset of hepatocellular carcinoma
July 23, 2020
Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens
November 3, 2019
Comprehensive serological profiling of human populations using asynthetic human virome
June 9, 2015